Aurora Spine Corporation
ASAPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $4,382 | $4,497 | $4,417 | $4,570 |
| % Growth | -2.6% | 1.8% | -3.3% | – |
| Cost of Goods Sold | $3,266 | $1,698 | $1,854 | $1,982 |
| Gross Profit | $1,116 | $2,799 | $2,563 | $1,062 |
| % Margin | 25.5% | 62.2% | 58% | 23.2% |
| R&D Expenses | $197 | $169 | $154 | $235 |
| G&A Expenses | $2,089 | $2,248 | $2,170 | $2,348 |
| SG&A Expenses | $2,331 | $2,481 | $2,414 | $2,672 |
| Sales & Mktg Exp. | $243 | $233 | $244 | $324 |
| Other Operating Expenses | -$1,339 | $280 | $267 | $7 |
| Operating Expenses | $1,189 | $2,930 | $2,835 | $2,914 |
| Operating Income | -$73 | -$130 | -$273 | -$442 |
| % Margin | -1.7% | -2.9% | -6.2% | -9.7% |
| Other Income/Exp. Net | -$67 | -$68 | -$77 | -$193 |
| Pre-Tax Income | -$140 | -$199 | -$350 | -$634 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$140 | -$199 | -$350 | -$634 |
| % Margin | -3.2% | -4.4% | -7.9% | -13.9% |
| EPS | -0.002 | -0.003 | -0.005 | -0.008 |
| % Growth | 30.8% | 42.2% | 45.1% | – |
| EPS Diluted | -0.002 | -0.003 | -0.005 | -0.008 |
| Weighted Avg Shares Out | 78,055 | 77,413 | 77,813 | 77,592 |
| Weighted Avg Shares Out Dil | 78,055 | 77,413 | 77,813 | 77,592 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $40 | $42 | $44 | $43 |
| Depreciation & Amortization | $240 | $280 | $267 | $253 |
| EBITDA | $140 | $123 | -$39 | -$337 |
| % Margin | 3.2% | 2.7% | -0.9% | -7.4% |